Home / Articles
How Stem Cells Are Used to Treat Ligament and Tendon Injuries
Home / Articles
How Stem Cells Are Used to Treat Ligament and Tendon Injuries
Tendon and ligament injuries are notoriously slow to heal. Unlike muscle or bone, these tissues have poor blood supply, making it difficult for the body to deliver nutrients and repair cells to the injury site. As a result, the healing process often results in disorganized scar tissue that lacks the strength and flexibility of healthy tissue.
At Seoul Yes Hospital, we frequently treat patients who have already tried standard therapies like physical therapy, corticosteroid injections, or even surgery—yet they continue to experience lingering pain, instability, or restricted movement. These cases highlight the limitations of traditional treatments and the growing interest in regenerative medicine, particularly stem cell therapy.
What makes tendons and ligaments so vulnerable to poor healing? Beyond vascular limitations, these structures endure repetitive mechanical stress and are often subject to microtears long before full injury is diagnosed. In Korea, where aging populations and recreational sports are both on the rise, chronic tendon and ligament issues are becoming increasingly common. Unfortunately, conventional approaches often manage symptoms without addressing the underlying tissue degeneration.
Stem cells, especially mesenchymal stem/stromal cells (MSCs), are uniquely suited to aid in the repair of tendons and ligaments. Here’s why:
MSCs can differentiate into various connective tissue types, including tenocytes (tendon cells) and fibroblasts (ligament cells). This means they can directly contribute to tissue regeneration where the body falls short. These cells also stimulate the recruitment of the body's native repair cells, amplifying the healing response beyond what’s normally possible.
Rather than merely filling the injury with scar tissue, stem cells help rebuild the organized collagen structure that tendons and ligaments require to function properly. Studies show that tissues repaired with stem cells more closely resemble the histology and mechanical strength of native tissue, which is critical for long-term durability.
Stem cells secrete bioactive molecules such as cytokines, exosomes, and growth factors that reduce chronic inflammation. This is particularly important for degenerative tendinopathies, where inflammation is low-grade but persistent, often leading to further tissue breakdown. These secreted factors also help modulate immune responses, minimizing scar formation and encouraging tissue repair.
Stem cells perform best when combined with structured rehabilitation and, in some cases, scaffolds that provide mechanical support and biological cues for healing. Research suggests that mechanical loading—such as the stress applied through carefully guided physical therapy—helps stem cells align collagen fibers and differentiate properly. When paired with advanced biomaterials, stem cells are more likely to thrive and contribute meaningfully to regeneration.
Let’s break down how this advanced therapy is applied in real clinical settings like ours at Seoul Yes Hospital.
It’s worth noting that the Korean medical system places a high value on non-surgical, outpatient therapies—making stem cell interventions particularly appealing to both local and international patients seeking advanced, minimally invasive care.
A 2022 systematic review analyzing 22 studies across 658 patients concluded that stem cell-based therapies are safe and likely beneficial in managing tendon disorders. In conditions such as rotator cuff injuries, comparative studies showed that patients receiving MSC therapy had significantly lower re-tear rates, better pain relief, and improved shoulder function.
In Achilles tendinopathy, pilot trials have shown structural improvements on MRI and ultrasound, correlating with reduced pain and improved mobility. These effects are believed to stem from both the direct regenerative impact of the cells and their ability to modulate the chronic inflammatory environment that impedes healing.
Preclinical studies using animal models have shown that MSCs improve the biomechanical strength of ligament repairs, especially in ACL reconstruction. They also promote better integration of the graft into the bone tunnel, a crucial factor for surgical success.
In early human trials, patients treated with stem-cell-augmented grafts reported faster recovery timelines and better functional scores. However, larger randomized clinical trials are needed to confirm long-term benefits.
Exosome therapy is emerging as a promising alternative to cell-based therapies. While still in early clinical stages, exosomes have demonstrated regenerative and anti-inflammatory effects similar to MSCs. Likewise, tendon-derived stem cells (TDSCs) offer a more tissue-specific approach, although they are currently limited to experimental use.
If you’re considering stem cell therapy for a tendon or ligament injury, ask:
What type of stem cells will be used, and where are they sourced from?
Will the cells be autologous (from your own body) or allogeneic (from a donor)?
How will the cells be delivered—via injection, surgical augmentation, or with scaffolds?
What is the rehabilitation plan, and how critical is adherence to it?
Are there published clinical results or real-world outcomes for this treatment in my condition?
What are the risks, side effects, and costs? Is the treatment covered by insurance in Korea?
How is success measured—pain reduction, return to activity, imaging results?
Stem cell therapy is not a magic cure. Success depends on many factors:
The patient’s age, overall health, and activity level
Severity and chronicity of the injury
Quality of the cell preparation and delivery
Adherence to a structured rehabilitation program
At Seoul Yes Hospital, we stress that stem cells are part of a broader strategy—not a standalone solution. We provide full-cycle care, integrating diagnostics, regenerative therapy, and post-procedural rehabilitation. Our goal is not just pain relief but meaningful recovery of function and quality of life.
His case reflects what we often see in clinic: individuals who are not necessarily elite athletes but value their mobility and lifestyle. Stem cell therapy, when applied correctly and supported by multidisciplinary care, can bridge the gap between chronic injury and functional recovery.
Located in Suji-gu, Yongin-si, we specialize in spine, joint, and regenerative care. Our hospital is led by Dr. Sung-Hoon Cho, a pioneer in NK cell therapy and regenerative medicine. With a team of 16+ experts, we offer:
Whether you’re an active adult, an athlete, or someone simply tired of ongoing pain, we can help you explore regenerative options that align with your lifestyle and recovery goals.
If you’re dealing with a stubborn tendon or ligament injury, and traditional treatments haven’t worked, stem cell therapy might be a valuable next step. At Seoul Yes Hospital, we blend innovation with compassionate care to help you heal—not just cope.
“If joint or tendon pain is affecting your lifestyle and you’ve been putting it off—you’re not alone. Exploring regenerative solutions at a specialized center that offers both innovation and experience may be the next right step.”
Let us know if you'd like to schedule a consultation or learn more about how regenerative medicine could support your recovery journey.